Masahiro Umeda

Masahiro Umeda

Auto-generated profile, based on publicly available information

Masahiro Umeda

Meiji University of Integrative Medicine Nantan Kyoto Japan

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2019 in Journal of Bone and Mineral Metabolism
Verified
Journal Article
Closed access
PDF file
SHSaki Hayashida
Saki Hayashida
SYSouichi YANAMOTO
Souichi YANAMOTO
SFShigeyuki Fujita
Shigeyuki Fujita
THTakumi Hasegawa
Takumi Hasegawa
TKTakahide Komori
Takahide Komori
MUMasahiro Umeda
Masahiro Umeda

1 February 2016 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
SYShin-ichi Yamada
Shin-ichi Yamada
SYSouichi YANAMOTO
Souichi YANAMOTO
SOShohei Otani
Shohei Otani
THTakumi Hasegawa
Takumi Hasegawa
MMM. Miyakoshi
M. Miyakoshi
MUM. Umeda
M. Umeda

1 January 2011 in Magnetic Resonance in Medical Sciences
Verified
Journal Article
Open access
PDF file
YMYuki Mori
Yuki Mori
MUMasahiro Umeda
Masahiro Umeda
MFMasaki Fukunaga
Masaki Fukunaga
KOKuniaki Ogasawara
Kuniaki Ogasawara
YYYoshichika Yoshioka
Yoshichika Yoshioka
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

1 March 2020 in Medicine
Verified
Journal Article
Open access
SYShin-ichi Yamada
Shin-ichi Yamada
SSSakiko Soutome
Sakiko Soutome
THTakumi Hasegawa
Takumi Hasegawa
ITItaru Tojyo
Itaru Tojyo
HNHirokazu Nakahara
Hirokazu Nakahara
HKHiroshi Kurita
Hiroshi Kurita
Patients develop a number of oral complications during cancer treatments. Oral bacteria are associated with the onset of dental focal infections and the progression of oral mucositis. Dental focal infections are frequently associated with the systemic onset of bacteremia, sepsis, and pneumonia. The degeneration of oral function with these complications may become an obstacle to cancer treatments. Although comprehensive oral management, including oral care, the removal of dental focal infections, and improvements in oral function with dentures, is conducted for cancer patients in Japan, few studies have assessed its efficacy. The aim of the present study was to investigate the incidence of dental/oral complications in cancer patients with perioperative oral managements (POMs) based on a large number of case series with a multicenter retrospective analysis. The medical records of cancer patients with POMs were retrospectively reviewed and the incidence of oral complications and efficacy of oral management were investigated. A total of 2744 cancer patients with POMs (1684 males and 1080 females, mean age 65.9 ± 13.0 years) were included and investigated in the present study. Among these patients, 2097 (76.4%) started POM before the initiation of cancer treatments, with 2130 (77.6%) receiving oral care only and 391 (14.2%) being subjected to invasive treatments, such as tooth extraction. The incidence of dental focal infections during the period of cancer treatments was 8.2%. The most frequent infection was acute periodontitis, including alveolar abscesses (112 patients, 4.1%). The incidence of grade 2 and 3 oral mucositis was 2.8%. Prolonged fever was observed in 113 patients (4.1%), with 7 having dental focal infections (6.2%). These incidence rates were lower than those reported previously. Based on analyses of a large number of patients, the present results support the efficacy of oral management in cancer patients. However, further studies are needed to establish adequate oral management guidelines for cancer patients.

1 January 2003 in Microsurgery
Verified
Journal Article
Closed access
PDF file
SYSatoshi Yokoo
Satoshi Yokoo
TKTakahide Komori
Takahide Komori
SFSyungo Furudoi
Syungo Furudoi
YSYasuyuki Shibuya
Yasuyuki Shibuya
MUMasahiro Umeda
Masahiro Umeda
Ken-ichi NibuKen-ichi Nibu
Ken-ichi Nibu

1 May 2005 in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
Verified
Journal Article
Open access
PDF file
TMTsutomu Minamikawa
Tsutomu Minamikawa
MUMasahiro Umeda
Masahiro Umeda
TKTakahide Komori
Takahide Komori
Although sentinel lymph node biopsy (SLNB) may reduce surgery-related complications related to unnecessary lymph node dissection and is now widely used for many patients with cutaneous melanoma and breast cancer, its use for oral cancer patients remains controversial. One of the main reasons for the reluctance to initiate SLNB for oral cancer is that the frequency of skip metastasis has not been clarified. The objectives of this study are to examine the frequency of skip metastasis and to evaluate SLNB for oral cancer. To shed light on these concerns, we first conducted a retrospective study of 296 patients with squamous cell carcinoma of the oral cavity who underwent neck dissection. Next, the accuracy of lymph node biopsy with and without detecting sentinel lymph node was examined. Ten patients showed skip neck metastasis in the level III-V region without level I-II involvement. Of these patients, 7 underwent neck dissection when their initially N0 neck progressed to N+, 2 underwent neck dissection when local recurrence occurred, and only 1 underwent surgery as an initial therapy. Most patients who underwent neck dissection as the initial therapy showed skip metastasis. Intraoperative lymph node biopsy without any attempt to detect sentinel lymph nodes by means of blue dye or lymphoscintigraphy was performed on 68 patients with oral cancer. Sixty-one (90%) were diagnosed correctly, whereas 7 diagnosed as N− actually had neck metastasis. SLNB with blue dye was performed on 21 patients. In 17 of them, sentinel lymph node was easily detected, resulting in a correct diagnosis for 16 patients (94%), while 1 with a false negative result actually had micrometastasis. These findings seem to suggest that SLNB is useful and can be applied to patients with oral cancer who undergo surgery as the initial therapy.